How much hydrocodone can i take
Pro Research Analysisby 
Searched over 200M research papers
Hydrocodone Dosage Guidelines
Introduction to Hydrocodone Usage
Hydrocodone is a widely prescribed opioid used for managing moderate to severe pain. It is available in various formulations, including immediate-release (IR) and extended-release (ER) tablets. Understanding the appropriate dosage is crucial for effective pain management and minimizing the risk of adverse effects and potential abuse.
Recommended Dosage for Hydrocodone Extended-Release (ER)
Hydrocodone ER formulations are designed to provide sustained pain relief with less frequent dosing. Studies have shown that hydrocodone ER can be administered in doses ranging from 45 mg to 90 mg twice daily. In one study, subjects received 45 mg twice daily for six days, while another group was titrated to 90 mg over ten days1. The pharmacokinetic profile indicated that steady-state plasma concentrations were achieved within five days of twice-daily administration, demonstrating sustained exposure with limited fluctuation1.
Dosage for Chronic Pain Management
For chronic pain, single-entity, once-daily hydrocodone tablets have been evaluated in doses ranging from 20 mg to 120 mg. In a study involving patients with chronic low back pain, the average daily dose was 57 mg, and the treatment was generally well tolerated2. This suggests that a daily dose within this range can be effective for managing chronic pain while minimizing adverse effects.
Immediate-Release (IR) Hydrocodone/Acetaminophen Combinations
Immediate-release hydrocodone/acetaminophen combinations are commonly prescribed for acute pain. The typical dosing regimen is one tablet every 4 to 6 hours, not exceeding 5 tablets per day. For example, a combination of hydrocodone 7.5 mg and acetaminophen 325 mg has been shown to be effective for acute low back pain, with similar efficacy and tolerability compared to other opioid combinations3.
Long-Term Use and Safety Considerations
Long-term use of IR hydrocodone/acetaminophen has been observed in a small percentage of patients, with most receiving doses between 20 mg and 60 mg per day. However, it is important to monitor acetaminophen intake to avoid exceeding the recommended maximum daily limit of 4 grams, as excessive acetaminophen can lead to liver damage4.
Abuse Potential and Safety Measures
Hydrocodone formulations with abuse-deterrent properties have been developed to reduce the risk of misuse. For instance, a study on the intranasal abuse potential of extended-release hydrocodone demonstrated reduced drug-liking and increased nasal irritation compared to hydrocodone powder, indicating lower abuse potential6. Additionally, combining hydrocodone with antiemetics like promethazine can help prevent opioid-induced nausea and vomiting, improving patient compliance and safety5.
Conclusion
The appropriate dosage of hydrocodone depends on the formulation, the severity of pain, and individual patient factors. For extended-release formulations, doses of 45 mg to 90 mg twice daily are common, while immediate-release combinations are typically dosed every 4 to 6 hours, not exceeding 5 tablets per day. Long-term use should be carefully monitored to avoid exceeding safe acetaminophen limits and to mitigate the risk of abuse. Always consult a healthcare provider to determine the most appropriate dosage for your specific condition.
Sources and full results
Most relevant research papers on this topic
Single- and multiple-dose pharmacokinetics of a hydrocodone bitartrate extended-release tablet formulated with abuse-deterrence technology in healthy, naltrexone-blocked volunteers.
The hydrocodone extended-release tablet with abuse-deterrence technology provides sustained pain relief with twice-daily dosing and has higher C(max) and AUC(0-t) than single-dose hydrocodone, with steady-state plasma concentration achieved within 5 days.
Non-RCTA multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain
Once-daily hydrocodone tablets effectively reduce pain and are well-tolerated in patients with uncontrolled chronic low back pain.
RCT
Large Human TrialCombination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.
Combination hydrocodone and ibuprofen is as effective and tolerable as combination oxycodone and acetaminophen for treating moderate or severe acute low back pain.
RCTA retrospective cohort study of long-term immediate-release hydrocodone/acetaminophen use and acetaminophen dosing above the Food and Drug Administration recommended maximum daily limit among commercially insured individuals in the United States (2008-2013).
Long-term immediate-release hydrocodone/acetaminophen use exceeds extended-release opioids, highlighting the need for safe use of both immediate-release and extended-release opioids.
Observational StudyPrevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg.
CL-108 is a safe and effective combination analgesic/antiemetic for preventing opioid-induced nausea and vomiting during treatment of moderate to severe acute pain.
RCTLarge Human Trial
Rigorous JournalIntranasal Abuse Potential, Pharmacokinetics, and Safety of Once-Daily, Single-Entity, Extended-Release Hydrocodone (HYD) in Recreational Opioid Users
Hysingla ER® (HYD) has reduced intranasal abuse potential compared to hydrocodone powder, with similar safety and pharmacokinetics.
RCTRigorous JournalA pharmacokinetic evaluation of single and multiple doses of extended-release hydrocodone bitartrate in subjects experiencing surgical or osteoarthritic pain.
Hydrocodone extended-release formulations provide sustained and effective pain relief with reduced peak-to-trough fluctuations, supporting twice-daily dosing with a 12-hour dosing interval.
RCTProfiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
Hydrocodone/acetaminophen products can produce abuse liability-related subjective effects in recreational drug users, with some unpleasant effects experienced by females.
RCTAnalgesic efficacy of a combination of hydrocodone with ibuprofen in postoperative pain *
The combination of hydrocodone and ibuprofen effectively reduces moderate to severe postoperative pain in women, outperforming both hydrocodone and ibuprofen alone.
RCT
Highly CitedHydrocodone excretion into breast milk: the first two reported cases.
Moderate doses of hydrocodone are acceptable during breastfeeding, but more data is needed to determine the maximum safe dosage for nursing mothers.
Case Report